Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Carasent AB (publ)APXZF 73 EV-to-OCF is 18.71 as of Aug. 20, 2026, which is 17% below its 10-year median of 22.63. GuruFocus rates APXZF with a GF Score™ of 73/100 and a GF Value™ of $0.16. The stock has 5 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Carasent AB (publ) ranks worse than 76.98% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Carasent AB (publ)'s Enterprise Value is $182.45 Mil.
Carasent AB (publ)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $9.75 Mil. Therefore, Carasent AB (publ)'s EV-to-OCF for today is 18.71.
The historical rank and industry rank for Carasent AB (publ)'s EV-to-OCF or its related term are showing as below:
APXZF'
s EV-to-OCF Range Over the Past 10 Years
Min: -542.01 Med: 22.63 Max: 757.98
Current: 19
During the past 13 years, the highest EV-to-OCF of Carasent AB (publ) was 757.98. The lowest was -542.01. And the median was 22.63.
APXZF's EV-to-OCF is ranked worse than 76.98% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.775
vs APXZF: 19.00
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Carasent AB (publ) (OTCPK:APXZF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Carasent AB (publ)'s PE Ratio (TTM) for today is calculated as:
Carasent AB (publ)'s share price for today is $0.15.
Carasent AB (publ)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.066.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Carasent AB (publ) EV-to-OCF Related Terms
Carasent AB (publ) EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Carasent AB (publ)'s EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s EV-to-OCF falls into.
Carasent AB (publ)'s current Enterprise Value is $182.45 Mil.
Carasent AB (publ)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carasent AB (publ) (APXZF) has a EV-to-OCF of 18.71 as of Aug. 20, 2026. This is 17% below median its historical median of 22.63. According to the industry distribution chart, Carasent AB (publ) ranks #525 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 77%.
Is Carasent AB (publ)'s EV-to-OCF too high?
Carasent AB (publ)'s current EV-to-OCF of 18.71 is 17% below median its 10-year median of 22.63. The Healthcare Providers & Services industry median EV-to-OCF is 8.78. Carasent AB (publ)'s value of 18.71 is 113.2% above this industry median. Based on the distribution chart, Carasent AB (publ) ranks #525 out of 682 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Carasent AB (publ) has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #525 out of 682 companies for EV-to-OCF. This places Carasent AB (publ) in the lower half of its industry. The industry median EV-to-OCF is 8.78. Carasent AB (publ)'s value of 18.71 is 113.2% above this benchmark. While the company's 10-year median is 22.63 vs. the industry median of 8.78, Carasent AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.78, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current EV-to-OCF of 18.71 is 113.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current EV-to-OCF is 18.71, which is 17% below median its own 10-year median of 22.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (APXZF) has a current EV-to-OCF of 18.71. The stock's GF Value™ is $0.16, compared to a current price of $0.15 — trading 6.3% below its estimated fair value. The current EV-to-OCF is 18.71, which is 17% below median its 10-year median of 22.63 and 113.2% above the Healthcare Providers & Services industry median of 8.78. Carasent AB (publ)'s overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Carasent AB (publ) (APXZF), the current EV-to-OCF is 18.71 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (APXZF) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of $0.15 is trading 6.3% below its estimated GF Value™ of $0.16.
Key valuation signals for APXZF:
EV-to-OCF: 18.71 (17% below median its 10-year median of 22.63)
GF Value™: $0.16 vs. price of $0.15 (6.3% below fair value)
Industry Position: 113.2% above the Healthcare Providers & Services median (#525 of 682)
No single metric tells the full story. See the APXZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
73GF Score
Get the complete analysis for APXZF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
APXZF has been successfully added to your 
